HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wesley Eddings Selected Research

Thromboembolism

5/2016Prediction of rates of thromboembolic and major bleeding outcomes with dabigatran or warfarin among patients with atrial fibrillation: new initiator cohort study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wesley Eddings Research Topics

Disease

2Atrial Fibrillation
05/2016 - 01/2016
1Chronic Disease (Chronic Diseases)
06/2017
1Hemorrhage
05/2016
1Thromboembolism
05/2016
1Osteonecrosis (Kienbock's Disease)
01/2016
1Osteoporosis
01/2016
1Type 2 Diabetes Mellitus (MODY)
09/2015
1Hyperlipidemias (Hyperlipidemia)
04/2015
1Rheumatoid Arthritis
04/2015

Drug/Important Bio-Agent (IBA)

1Generic DrugsIBA
06/2017
1DabigatranFDA Link
05/2016
1Warfarin (Coumadin)FDA LinkGeneric
05/2016
1Diphosphonates (Bisphosphonates)IBA
01/2016
1Hypoglycemic Agents (Hypoglycemics)IBA
09/2015
1Insulin (Novolin)FDA Link
09/2015
1LipidsIBA
04/2015
1Hydroxychloroquine (Plaquenil)FDA LinkGeneric
04/2015
1Antirheumatic Agents (DMARD)IBA
04/2015